A series of twenty chalcone derivatives was synthetized and their anti-proliferative activity was tested against the human T-cell acute lymphoblastic leukemia-derived cell line (CCRF-CEM).Based on the structural features of the most active compounds a new library of chalcone derivatives, according to SAR design, was synthetized and their antiproliferative activity was tested on the same cancer cell line. Four of them (compounds 3, 4, 8, 28), based on lower IC50 values (between 6.1 and 8.9 M), were selected for further investigation regarding the modulation of the protein expression of receptor for activated C kinase (RACK1), PKCα and PKCβ, and their action at cell cycle level.Cell cycle analysis indicated a block in G0/G1 phase for all four compounds, with a statistically significant decrease in the percentage of cells in S phase, with no indication of apoptosis (subG0/G1 phase). Compounds 4 and 8 showed a statistical significant reduction in the expression of PKCα and an increase in PKCβ, which together with the demonstration of an antiproliferative role of PKCβ as assessed by treating cells with a selective PKCβ activator, indicated that the antiproliferative effect observed is likely to be mediated through PKCβ induction.